Biblio

Export 4 results:
Author Title Type [ Year(Desc)]
Filters: Author is Porsteinsson, Anton P  [Clear All Filters]
2014
S. Salloway, Sperling, R., Fox, N. C., Blennow, K., Klunk, W., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., Ferris, S., Reichert, M., Ketter, N., Nejadnik, B., Guenzler, V., Miloslavsky, M., Wang, D., Lu, Y., Lull, J., Tudor, I. Cristina, Liu, E., Grundman, M., Yuen, E., Black, R., and H Brashear, R., “Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.”, N Engl J Med, vol. 370, no. 4, pp. 322-33, 2014.
2016
P. B. Rosenberg, Lanctôt, K. L., Herrmann, N., Mintzer, J. E., Porsteinsson, A. P., Sun, X., and Raman, R., “Changes in Neuropsychiatric Inventory Associated with Semagacestat Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 1, pp. 373-81, 2016.
2017
F. Lin, Ren, P., Lo, R. Y., Chapman, B. P., Jacobs, A., Baran, T. M., Porsteinsson, A. P., and Foxe, J. J., “Insula and Inferior Frontal Gyrus' Activities Protect Memory Performance Against Alzheimer's Disease Pathology in Old Age.”, J Alzheimers Dis, vol. 55, no. 2, pp. 669-678, 2017.
2018
S. P. Salloway, Sperling, R., Fox, N. C., Sabbagh, M. N., Honig, L. S., Porsteinsson, A. P., Rofael, H., Ketter, N., Wang, D., Liu, E., Carr, S., Black, R. S., and H Brashear, R., “Long-Term Follow Up of Patients with Mild-to-Moderate Alzheimer's Disease Treated with Bapineuzumab in a Phase III, Open-Label, Extension Study.”, J Alzheimers Dis, vol. 64, no. 3, pp. 689-707, 2018.